IntegraGen SA (ALINT.PA)

EUR 0.53

(0.0%)

Total Assets Summary of IntegraGen SA

  • IntegraGen SA's latest annual total assets in 2023 was 8 Million EUR , down -11.33% from previous year.
  • IntegraGen SA's latest quarterly total assets in 2024 Q2 was 6.21 Million EUR , down 0.0% from previous quarter.
  • IntegraGen SA reported annual total assets of 9.02 Million EUR in 2022, down -6.05% from previous year.
  • IntegraGen SA reported annual total assets of 9.6 Million EUR in 2021, up 8.87% from previous year.
  • IntegraGen SA reported quarterly total assets of 10.75 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • IntegraGen SA reported quarterly total assets of 8 Million EUR for 2023 FY, down -11.33% from previous quarter.

Annual Total Assets Chart of IntegraGen SA (2023 - 2008)

Historical Annual Total Assets of IntegraGen SA (2023 - 2008)

Year Total Assets Total Assets Growth
2023 8 Million EUR -11.33%
2022 9.02 Million EUR -6.05%
2021 9.6 Million EUR 8.87%
2020 8.82 Million EUR 30.74%
2019 6.74 Million EUR -21.38%
2018 8.58 Million EUR -0.77%
2017 8.64 Million EUR 13.96%
2016 7.58 Million EUR -11.95%
2015 8.61 Million EUR -6.0%
2014 9.17 Million EUR 58.55%
2013 5.78 Million EUR -26.36%
2012 7.85 Million EUR 12.73%
2011 6.96 Million EUR -14.82%
2010 8.18 Million EUR 95.36%
2009 4.18 Million EUR 17.07%
2008 3.57 Million EUR 0.0%

Peer Total Assets Comparison of IntegraGen SA

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR 45.613%
ABIVAX Société Anonyme 327.06 Million EUR 97.554%
Adocia SA 24.95 Million EUR 67.942%
Aelis Farma SA 26.28 Million EUR 69.558%
Biophytis S.A. 11.93 Million EUR 32.973%
Advicenne S.A. 12.4 Million EUR 35.517%
genOway Société anonyme 31.84 Million EUR 74.875%
Medesis Pharma S.A. 1.92 Million EUR -315.315%
Neovacs S.A. 47.53 Million EUR 83.169%
NFL Biosciences SA 3.97 Million EUR -101.488%
Plant Advanced Technologies SA 14.91 Million EUR 46.353%
Quantum Genomics Société Anonyme 3.74 Million EUR -113.527%
Sensorion SA 46.49 Million EUR 82.793%
Theranexus Société Anonyme 7.23 Million EUR -10.537%
TME Pharma N.V. 2.49 Million EUR -221.17%
Valbiotis SA 33.24 Million EUR 75.937%
TheraVet SA 7.53 Million EUR -6.187%
Valerio Therapeutics Société anonyme 35.27 Million EUR 77.319%
argenx SE 4.11 Billion EUR 99.805%
BioSenic S.A. 9.55 Million EUR 16.306%
Celyad Oncology SA 16.28 Million EUR 50.864%
DBV Technologies S.A. 165.65 Million USD 95.17%
Galapagos NV 4.35 Billion EUR 99.816%
Genfit S.A. 173.87 Million EUR 95.399%
GeNeuro SA 6.31 Million EUR -26.73%
Hyloris Pharmaceuticals SA 47.68 Million EUR 83.221%
Innate Pharma S.A. 184.19 Million EUR 95.657%
Inventiva S.A. 69.13 Million EUR 88.429%
MaaT Pharma SA 42.93 Million EUR 81.365%
MedinCell S.A. 36.94 Million EUR 78.347%
Nanobiotix S.A. 93.89 Million EUR 91.48%
Onward Medical N.V. 43.62 Million EUR 81.663%
Oryzon Genomics S.A. 106.9 Million EUR 92.516%
OSE Immunotherapeutics SA 81.9 Million EUR 90.232%
Oxurion NV 6.55 Million EUR -22.143%
Pharming Group N.V. 426.33 Million EUR 98.123%
Poxel S.A. 4.82 Million EUR -65.879%
GenSight Biologics S.A. 9.08 Million EUR 11.958%
Transgene SA 45.21 Million EUR 82.307%
Financière de Tubize SA 1.92 Billion EUR 99.583%
UCB SA 15.53 Billion EUR 99.949%
Valneva SE 469.39 Million EUR 98.296%
Vivoryon Therapeutics N.V. 30.82 Million EUR 74.049%